You just read:

Amylin to Present Data Showing Investigational Metreleptin Treatment Led to Long-Term Improvements in Diabetes and Lipid Control in Patients with Lipodystrophy

News provided by

Amylin Pharmaceuticals, Inc.

Apr 15, 2011, 09:00 ET